Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer

被引:159
作者
Fu, Z
Kitagawa, Y
Shen, RL
Shah, R
Mehra, R
Rhodes, D
Keller, PJ
Mizokami, A
Dunn, R
Chinnaiyan, AM
Yao, Z
Keller, ET
机构
[1] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Kanazawa Univ, Dept Urol, Kanazawa, Ishikawa 920, Japan
[4] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China
关键词
prognostic marker; RKIP; prostate cancer; metastasis suppressor gene; tissue microarray;
D O I
10.1002/pros.20319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Diminished expression of Raf kinase inhibitor protein (RKIP), an inhibitor of the Raf signaling cascade, promotes prostate cancer (PCa) metastasis in a murine model, suggesting that it is a metastasis suppressor gene. However, the prognostic significance of RKIP expression and its association with metastasis in PCa patients is unknown. METHODS. To investigate RKIP protein expression is a prognostic marker in PCa we performed immunohistochemical staining for RKIP expression in tissue microarrays consisting of 758 non-neoplastic prostate tissues, primary tumors and metastases from 134 PCa patients. The Cox proportional-hazards model was used to adjust for covariates including Gleason score, tumor volume, tumor weight, clinical stage, digital rectal exam findings, serum PSA level and surgical margins. RESULTS. RKIP expression was low in approximately 5%, 48%, and 89% of non-neoplastic prostate, primary tumors and metastases, respectively. Low RKIP expression in primary tumors was a strong positive predictive factor for PCa recurrence based on PSA levels. In patients whose primary tumors expressed high RKIP levels, the 7-year PSA recurrence rate was < 10%; whereas in patients with tumors with low RKIP expression the recurrence rate was 50% (P < 0.001). Multivariate analysis revealed RKIP was an independent prognostic factor (P < 0.001). CONCLUSION. In contrast to increased expression of pro-tumorigenic genes, these results demonstrate decreased protein expression of a gene, for example, RKIP, can serve as a prognostic marker in PCa patients.
引用
收藏
页码:248 / 256
页数:9
相关论文
共 46 条
[31]   SEQUENCE-ANALYSIS OF A MAMMALIAN PHOSPHOLIPID-BINDING PROTEIN FROM TESTIS AND EPIDIDYMIS AND ITS DISTRIBUTION BETWEEN SPERMATOZOA AND EXTRACELLULAR SECRETIONS [J].
PERRY, ACF ;
HALL, L ;
BELL, AE ;
JONES, R .
BIOCHEMICAL JOURNAL, 1994, 301 :235-242
[32]  
Pettaway C A, 1998, Tech Urol, V4, P35
[33]   Natural history of progression after PSA elevation following radical prostatectomy [J].
Pound, CR ;
Partin, AW ;
Eisenberger, MA ;
Chan, DW ;
Pearson, JD ;
Walsh, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1591-1597
[34]   ONCOMINE:: A cancer microarray database and integrated data-mining platform [J].
Rhodes, DR ;
Yu, JJ ;
Shanker, K ;
Deshpande, N ;
Varambally, R ;
Ghosh, D ;
Barrette, T ;
Pandey, A ;
Chinnaiyan, AM .
NEOPLASIA, 2004, 6 (01) :1-6
[35]  
Roberts SG, 2001, MAYO CLIN PROC, V76, P576
[36]   Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy [J].
Roberts, WW ;
Bergstralh, EJ ;
Blute, ML ;
Slezak, JM ;
Carducci, M ;
Han, M ;
Epstein, JI ;
Eisenberger, MA ;
Walsh, PC ;
Partin, AW .
UROLOGY, 2001, 57 (06) :1033-1037
[37]  
Rubin MA, 2000, CLIN CANCER RES, V6, P1038
[38]   RADICAL PROSTATECTOMY - PATTERNS OF LOCAL FAILURE AND SURVIVAL IN 67 PATIENTS [J].
SCHELLHAMMER, PF .
UROLOGY, 1988, 31 (03) :191-197
[39]  
Schindl M, 2000, ANTICANCER RES, V20, P4551
[40]   Prostate cancer detection at low prostate specific antigen [J].
Schröder, FH ;
van der Cruijsen-Koeter, I ;
de Koning, HJ ;
Vis, AN ;
Hoedemaeker, RF ;
Kranse, R .
JOURNAL OF UROLOGY, 2000, 163 (03) :806-811